Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor

Last updated: April 9, 2025
Sponsor: Khyber Teaching Hospital
Overall Status: Active - Recruiting

Phase

4

Condition

Yeast Infections

Sunspot Fungus (Tinea Versicolor)

Treatment

Fluconazole

Itraconazole

Clinical Study ID

NCT06922344
84/DME/KMC
  • Ages 18-50
  • All Genders

Study Summary

This study compares the efficacy of two drugs, namely flucanazole and itraconazole for the treatment of a common fungal infection of skin.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All cases of Pityriasis versicolor

Exclusion

Exclusion Criteria:

  • Patients with history of chronic renal or liver disease, malignancy , or undergoingany kind of chemotherapy or radiotherapy or having cardiac conduction abnormalities.

  • Patients who received any anti-fungal therapy in the last one month.

  • Pregnant or lactating women.

Study Design

Total Participants: 106
Treatment Group(s): 2
Primary Treatment: Fluconazole
Phase: 4
Study Start date:
March 01, 2025
Estimated Completion Date:
December 31, 2025

Study Description

Pityriasis versicolor is a common fungal infection of the superficial skin layers. Avalible treatment options include topical and systemic drugs. fluconazole and itraconazole are commonly used systemic agents. The aim of this study is to compare the efficacy of the two systemic drugs.

Connect with a study center

  • Khyber Teaching Hospital

    Peshawar, KPK 25000
    Pakistan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.